Lang AE - Search Results

1

Crossroads in GDNF therapy for Parkinson's disease.

Sherer TB, Fiske BK, Svendsen CN, Lang AE, Langston JW. Sherer TB, et al. Among authors: lang ae. Mov Disord. 2006 Feb;21(2):136-41. doi: 10.1002/mds.20861. Mov Disord. 2006. PMID: 16470786

2

Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study.

Stefurak T, Mikulis D, Mayberg H, Lang AE, Hevenor S, Pahapill P, Saint-Cyr J, Lozano A. Stefurak T, et al. Among authors: lang ae. Mov Disord. 2003 Dec;18(12):1508-16. doi: 10.1002/mds.10593. Mov Disord. 2003. PMID: 14673888

3

Analysis of the glucocerebrosidase gene in Parkinson's disease.

Sato C, Morgan A, Lang AE, Salehi-Rad S, Kawarai T, Meng Y, Ray PN, Farrer LA, St George-Hyslop P, Rogaeva E. Sato C, et al. Among authors: lang ae. Mov Disord. 2005 Mar;20(3):367-70. doi: 10.1002/mds.20319. Mov Disord. 2005. PMID: 15517592

4

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.

Hauser RA, Rascol O, Korczyn AD, Jon Stoessl A, Watts RL, Poewe W, De Deyn PP, Lang AE. Hauser RA, et al. Among authors: lang ae. Mov Disord. 2007 Dec;22(16):2409-17. doi: 10.1002/mds.21743. Mov Disord. 2007. PMID: 17894339 Clinical Trial.

5

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. Zadikoff C, et al. Among authors: lang ae. Mov Disord. 2008 Jan 30;23(2):297-9. doi: 10.1002/mds.21837. Mov Disord. 2008. PMID: 18044697

6

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.

Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C; Multicentre Advanced Parkinson's Disease Deep Brain Stimulation Group. Hariz MI, et al. Mov Disord. 2008 Feb 15;23(3):416-21. doi: 10.1002/mds.21888. Mov Disord. 2008. PMID: 18067188 Clinical Trial.

7

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators. Ravina B, et al. Among authors: lang ae. Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690. Mov Disord. 2009. PMID: 19691116

8

The nonmotor symptoms of Parkinson's disease--an overview.

Lim SY, Lang AE. Lim SY, et al. Among authors: lang ae. Mov Disord. 2010;25 Suppl 1:S123-30. doi: 10.1002/mds.22786. Mov Disord. 2010. PMID: 20187234 Review.

9

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease.

Bronzova J, Sampaio C, Hauser RA, Lang AE, Rascol O, Theeuwes A, van de Witte SV, van Scharrenburg G; Bruegel Study Group. Bronzova J, et al. Among authors: lang ae. Mov Disord. 2010 Apr 30;25(6):738-46. doi: 10.1002/mds.22948. Mov Disord. 2010. PMID: 20198713 Clinical Trial.

10

Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD).

Vitek JL, Lyons KE, Bakay R, Benabid AL, Deuschl G, Hallett M, Kurlan R, Pancrazio JJ, Rezai A, Walter BL, Lang AE. Vitek JL, et al. Among authors: lang ae. Mov Disord. 2010 Aug 15;25(11):1530-7. doi: 10.1002/mds.23151. Mov Disord. 2010. PMID: 20544809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,165 results

Search Page

Filters